Related Experiment Videos
bcl 10 gene mutation in hepatocellular carcinoma
1Department of Surgery, Peking University People's Hospital, Beijing 100044, China.
Chinese Medical Journal
|January 10, 2002
Summary
The bcl 10 gene shows a high mutation frequency in liver cancer, with mutations detected in over half of early and advanced hepatocellular carcinoma (HCC) cases. These bcl 10 gene mutations were not significantly related to tumor size or AFP levels.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Hepatocellular carcinoma (HCC) is a significant global health concern.
- Understanding the genetic alterations in HCC is crucial for developing targeted therapies.
Purpose of the Study:
- To determine the mutation frequency of the bcl 10 gene in both early and advanced stages of HCC.
- To investigate the correlation between bcl 10 gene mutations and clinical parameters such as serum alpha-fetoprotein (AFP) levels and tumor size.
Main Methods:
- Genomic DNA was extracted from 46 HCC tumor and adjacent non-tumor tissues.
- Polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) was employed to detect mutations in three exons of the bcl 10 gene.
- Sequencing was performed on abnormal DNA bands to confirm mutations, and statistical analyses were conducted to assess relationships with clinical factors.
Main Results:
- Mutations in the bcl 10 gene were frequent, observed in 56.5% of cases in exon 1, 54.3% in exon 2, and 45.7% in exon 3.
- Specific mutations identified include 5744 C-->G, 11,311 T deletion, and 14,116 C-->T.
- No significant association was found between bcl 10 gene mutations and serum AFP levels or tumor size in HCC patients.
Conclusions:
- The bcl 10 gene exhibits a high mutation frequency in liver cancer.
- These findings suggest that bcl 10 gene mutations are common in HCC and may play a role in its pathogenesis.